Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation
NCT05404711
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Overweight and Obesity
PreDiabetes
Insulin Resistance
Interventions
DEVICE:
CGM
Sponsor
Mary Ellen Vajravelu, MD